469 related articles for article (PubMed ID: 32469437)
1. A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.
Ren YR; Golding A; Sorbello A; Ji P; Chen J; Saluja B; Witzmann K; Arya V; Reynolds KS; Choi SY; Nikolov NP; Sahajwalla C
J Clin Pharmacol; 2020 Aug; 60(8):954-975. PubMed ID: 32469437
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
Schijns V; Lavelle EC
Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
[TBL] [Abstract][Full Text] [Related]
3. Statin therapy and SAR-COV-2: an available and potential therapy?
Abdel-Latif RG; Mohammed S; Elgendy IY
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
[No Abstract] [Full Text] [Related]
4. COVID-19: Small-Molecule Clinical Trials Landscape.
Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
[No Abstract] [Full Text] [Related]
5. Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies.
Zhao M
Int J Antimicrob Agents; 2020 Jun; 55(6):105982. PubMed ID: 32305588
[TBL] [Abstract][Full Text] [Related]
6. Emergence of novel coronavirus and progress toward treatment and vaccine.
Khan MM; Noor A; Madni A; Shafiq M
Rev Med Virol; 2020 Jul; 30(4):e2116. PubMed ID: 32495979
[TBL] [Abstract][Full Text] [Related]
7. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
8. Microbicidal actives with virucidal efficacy against SARS-CoV-2.
Ijaz MK; Whitehead K; Srinivasan V; McKinney J; Rubino JR; Ripley M; Jones C; Nims RW; Charlesworth B
Am J Infect Control; 2020 Aug; 48(8):972-973. PubMed ID: 32461067
[No Abstract] [Full Text] [Related]
9. COVID-19: The Need for Immunoprevention at Industrial Scale.
Halstead SB
Am J Trop Med Hyg; 2020 Jun; 102(6):1151. PubMed ID: 32274985
[No Abstract] [Full Text] [Related]
10. Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Apr; 382(16):e58. PubMed ID: 32320592
[No Abstract] [Full Text] [Related]
11. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy.
Poulas K; Farsalinos K; Zanidis C
Front Immunol; 2020; 11():1373. PubMed ID: 32612613
[No Abstract] [Full Text] [Related]
12. Combination prevention for COVID-19.
Cohen MS; Corey L
Science; 2020 May; 368(6491):551. PubMed ID: 32381692
[No Abstract] [Full Text] [Related]
13. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine as a prophylactic agent against COVID-19?
Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
[TBL] [Abstract][Full Text] [Related]
15. COVID-19: Some clinical questions after the first 4 months.
Bassetti M; Ansaldi F; Icardi G; Pelosi P; Robba C; Taramasso L; Trucchi C; Vena A; Giacobbe DR
Eur J Clin Invest; 2020 Jul; 50(7):e13326. PubMed ID: 32562550
[No Abstract] [Full Text] [Related]
16. Optimizing COVID-19 Candidate Therapeutics: Thinking Without Borders.
Rayner CR; Smith PF; Hershberger K; Wesche D
Clin Transl Sci; 2020 Sep; 13(5):830-834. PubMed ID: 32212378
[No Abstract] [Full Text] [Related]
17. John-Arne Røttingen.
Mullard A
Nat Rev Drug Discov; 2020 May; 19(5):302-303. PubMed ID: 32286497
[No Abstract] [Full Text] [Related]
18.
Siddiqui R; Khan NA
ACS Chem Neurosci; 2020 Aug; 11(16):2391-2392. PubMed ID: 32786329
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2: a time for clear and immediate action.
Poland GA
Lancet Infect Dis; 2020 May; 20(5):531-532. PubMed ID: 32243818
[No Abstract] [Full Text] [Related]
20. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
Li H; Liu Z; Ge J
J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]